Trump's Tariff Threat Puts Pharma Stocks Under Pressure

U.S. President Trump’s threat of a 200% tariff on pharma imports has raised alarm for Indian drug exporters. With generic margins thin, shifting production or hiking prices may be unviable, risking U.S. drug shortages. Pharma stocks have already weakened, with brokerage downgrades adding to the sector’s ongoing pressure.